Statins in the treatment of atherogenic dislipidemia

Journal Title: Terapeutica, Farmacologie si Toxicologie Clinica - Year 2008, Vol 12, Issue 3

Abstract

Statins are the most usefull drugs in the treatment of atherogenic dislipidemia. The benefit of statins was demonstrated in primary and secondary prevention of cardiovascular disease and consists in reduction of major cardiovascular events. The clinical benefit is associated with decreasing in LDL-c levels. New data seems to be needed to establish optimal LDL-c levels in secondary prevention. The benefit is greater and with cost-efficiency in high cardiovascular risk patients. When used in moderate dosage statins are well tolerated drugs but high statins therapeutic regimen is associated with enhanced risk in increasing of liver enzymes levels.

Authors and Affiliations

Maria Rădoi

Keywords

Related Articles

Quantum medicine

BRT is the therapy with electromagnetic oscillations, structures of the organism come into resonance with them. The influence is possible on cellular level as at the level of organ, system of organs and whole body. The...

Endogenous cannabinoid system. pharmacological implications, pharmacotherapeutical perspectives and the new drugs.

This paper represents a review of the up-to-date knowledge about endogenous cannabinoid system (SCBE): pharmacological implications correlated with mechanism type (agonist, antagonist, endocannabinoid metabolize catalyzi...

Statins in the treatment of atherogenic dislipidemia

Statins are the most usefull drugs in the treatment of atherogenic dislipidemia. The benefit of statins was demonstrated in primary and secondary prevention of cardiovascular disease and consists in reduction of major ca...

The oxidative stress impact on the brain aging

The brain aging is a complex process with anatomical, chemical and functional impact. The structural changes are not homogenonous and are related with engenous and exogenous factors. Brain aging is influenced by the ox...

Strontium - clinical and paraclinical aspects

[b]Introduction:[/b] Stable Strontium -meaning nonradioactive- is nontoxic, even when administered in large doses for prolonged periods. It also appears to be one of the most effective substances yet found for the preven...

Download PDF file
  • EP ID EP83079
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

Maria Rădoi (2008). Statins in the treatment of atherogenic dislipidemia. Terapeutica, Farmacologie si Toxicologie Clinica, 12(3), 341-348. https://www.europub.co.uk/articles/-A-83079